T1	p 74 140	patients with chemotherapy-induced painful peripheral neuropathy :
T2	p 468 680	8 National Cancer Institute ( NCI ) -funded cooperative research networks that enrolled 231 patients who were 25 years or older being treated at community and academic settings between April 2008 and March 2011 .
T3	i 430 448	placebo-controlled
T4	i 827 868	duloxetine followed by placebo or placebo
T5	i 1133 1187	paclitaxel , other taxane , or oxaliplatin treatment .
T6	i 1279 1300	duloxetine or placebo
T7	i 1354 1406	duloxetine or placebo daily for 4 additional weeks .
T8	i 1501 1508	placebo
T9	i 1942 1949	placebo
T10	i 2050 2072	duloxetine and placebo
T11	i 2386 2393	placebo
T12	o 30 67	pain , function , and quality of life
T13	o 1512 1587	decreasing chemotherapy-induced peripheral neuropathic pain . Pain severity
T14	o 1611 1660	Brief Pain Inventory-Short Form average pain item
T15	o 2023 2041	average pain score
T16	o 2441 2445	pain